S&CO Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.28M | Hold |
10,050
| – | – | 0.21% | 90 |
|
2025
Q1 | $2.71M | Buy |
10,050
+4,300
| +75% | +$1.16M | 0.18% | 100 |
|
2024
Q4 | $1.35M | Hold |
5,750
| – | – | 0.09% | 124 |
|
2024
Q3 | $1.58M | Hold |
5,750
| – | – | 0.1% | 125 |
|
2024
Q2 | $1.4M | Hold |
5,750
| – | – | 0.1% | 127 |
|
2024
Q1 | $859K | Buy |
+5,750
| New | +$859K | 0.06% | 142 |
|